Snowflake in spotlight as TD Cowen sees 'constructive' partner checks ahead of Q4 results
Snowflake (NYSE:SNOW) was in the spotlight on Friday as TD Cowen said recent partner checks were “constructive” ahead of the ...
TD Cowen cuts Freshpet target, calls selloff overdone
TD Cowen lowered the firm’s price target on Freshpet (FRPT) to $141 from $174 and keeps a Buy rating on the shares post the Q4 report.
Walmart's future is bright, says TD Cowen's Oliver Chen
Oliver Chen, TD Cowen senior retail analyst, joins 'Money Movers' to discuss Wall Street's reaction to Walmart's quarterly ...
Inventiva initiated with a Buy at TD Cowen
TD Cowen initiated coverage of Inventiva (IVA) with a Buy rating and $10 price target The firm thinks the company’s oral pan-PPAR agonist ...
GRAIL to Present at TD Cowen 45th Annual Health Care Conference
GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the TD Cowen 45th Annual Health ...
InvestmentNews4mon
TD Cowen
TD Cowen was established in 1918 as a bond trading firm and quickly expanded into clearing and execution services. By the 1970s, it had carved a niche in railroad bonds and grown a solid research ...
Charles Schwab (NYSE:SCHW) Upgraded by TD Cowen to “Buy” Rating
Charles Schwab (NYSE:SCHW – Get Free Report) was upgraded by equities researchers at TD Cowen from a “hold” rating to a “buy” ...
Vistagen to Participate in the 45th Annual TD Cowen Healthcare Conference
Vistagen (Nasdaq: VTGN), a clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates ...
manilatimes6h
Madrigal Pharmaceuticals to Participate in the 45th Annual TD Cowen Health Care Conference
CONSHOHOCKEN, Pa., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the company will participate in the 45th Annual TD Cowen Health Care Conference ...
Investing17h
Walmart stock pullback a ‘buy opportunity,’ TD says
Investing.com-- TD Cowen analysts said a pullback in Walmart Inc (NYSE: WMT ), on weaker-than-expected guidance, represented a buy opportunity for the stock, and that they still saw the retail giant ...
Nasdaq1mon
Centessa initiated with a Buy at TD Cowen
TD Cowen initiated coverage of Centessa (CNTA) with a Buy rating and no price target The firm says the company’s ORX750 has a “best in class profile as a transformative therapy” in excessive ...
Nasdaq1mon
KalVista initiated with a Buy at TD Cowen
TD Cowen initiated coverage of KalVista (KALV) with a Buy rating and $30 price target The firm cites sebetralstat’s opportunity as the first oral acute therapy for hereditary angioedema attacks ...